Our team uses a consistent, validated approach to develop novel sibased therapeutics for significant markets with high unmet clinical need. Using a proprietary algorithm for sisequence prediction against known gene targets we can rapidly identify siRNAs for use against traditionally "non-drugable" targets ...
Pipeline
is leveraging an unsurpassed level of knowledge and experience in interference (RNAi) technology and forging a path to high value creation with exciting clinical product development programs in multiple therapeutic areas...